Physician profile
Anthony E Holt
NPI 1134239049
$14,055.60
in general payments reported to CMS, 2019-2025
61 companies · $3,089 in 2025
The $3,089 reported for 2025 was more than what a typical Neuromuscular Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $530).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,761 · 2020: $1,528 · 2021: $1,732 · 2022: $1,923 · 2023: $1,885 · 2024: $2,137 · 2025: $3,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,110.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,476.27 | 2021-2025 | |
| Biogen, INC. | $1,346.41 | 2019-2025 | Vumerity, Leqembi, Tysabri |
| Novartis Pharmaceuticals Corporation | $891.74 | 2019-2025 | |
| Emd Serono, INC. | $876.38 | 2019-2025 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $744.79 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Supernus Pharmaceuticals, INC. | $578.70 | 2019-2025 | Qelbree |
| Ucb, INC. | $499.32 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Eisai INC. | $470.88 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $445.23 | 2019-2025 | Nuplazid, Daybue |
| Genzyme Corporation | $432.33 | 2019-2025 | |
| Allergan, INC. | $416.48 | 2019-2022 | |
| Lundbeck LLC | $404.28 | 2022-2025 | Vyepti, Rexulti |
| Argenx US, INC. | $388.73 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Amgen INC. | $357.49 | 2019-2025 | Uplizna, Aimovig |
| Sk Life Science, INC. | $354.14 | 2020-2025 |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.